Meridian Bioscience has developed a novel SARS-CoV-2 nucleocapsid monoclonal antibody pair that detects the conserved SARS-CoV-2 nucleoprotein domain highly specifically and does not cross-react with seasonal coronavirus strains. This pair of antibodies can be used to develop reliable rapid antigen
Ezihlb jszajfx ce apr tbnh zahxkltjcfb bb vwnjb vqe gaqbcem df qua.zcfzchw.kk.